Display Settings:

Format

Send to:

Choose Destination

    Clin Rheumatol. 2004 Jun;23(3):269-71. Epub 2004 Apr 14.

    Fatal exacerbation of paraneoplastic systemic sclerosis after neoadjuvant chemotherapy in a breast cancer patient.

    Kochhar R, Umbreit JN.

    Winship Cancer Institute, Emory University School of Medicine, PO Box 55440, Atlanta, GA 30308, USA. Ruby_Kochhar@emory.org

    Paraneoplastic systemic sclerosis (SSc) occurs in about 3%-7% of individuals with SSc. There are reports of accelerated SSc syndromes associated in particular with breast cancer. Further exacerbations of the rheumatic condition may be induced by treatment of the cancer. We report a 30-year-old African-American woman with a contiguous diagnosis of breast cancer and paraneoplastic SSc. She was treated with neoadjuvant chemotherapy and developed an accelerated SSc syndrome with pericarditis and cardiac tamponade, with lethal results. This case report stresses the need for control of the rheumatic condition prior to the initiation of antineoplastic therapy.

    PMID: 15168161 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information